Claritev (NYSE:CTEV) Stock Rating Upgraded by Zacks Research

Claritev (NYSE:CTEV) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Thursday,Zacks.com reports.

Several other analysts also recently weighed in on CTEV. Barclays assumed coverage on Claritev in a research report on Friday, April 24th. They issued an “overweight” rating and a $28.00 price objective for the company. Piper Sandler reaffirmed an “overweight” rating and issued a $73.00 target price on shares of Claritev in a research note on Wednesday. Canaccord Genuity Group upped their price target on shares of Claritev from $37.00 to $43.00 and gave the company a “buy” rating in a report on Monday, August 10th. Citigroup reissued a “buy” rating and set a $45.00 price target (up from $40.00) on shares of Claritev in a research report on Monday. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Claritev in a report on Wednesday, June 24th. Six analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $42.83.

Claritev Price Performance

Shares of CTEV stock opened at $38.51 on Thursday. The stock has a market capitalization of $652.74 million, a PE ratio of -2.26 and a beta of 0.74. Claritev has a 1-year low of $11.50 and a 1-year high of $74.07. The business has a 50-day moving average of $29.85 and a 200 day moving average of $24.05.

Insider Buying and Selling at Claritev

In other news, SVP William B. Mintz sold 8,431 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $34.24, for a total transaction of $288,677.44. Following the transaction, the senior vice president directly owned 71,195 shares of the company’s stock, valued at approximately $2,437,716.80. The trade was a 10.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 7.40% of the company’s stock.

Institutional Trading of Claritev

Large investors have recently added to or reduced their stakes in the stock. FAS Wealth Partners Inc. increased its position in Claritev by 49.5% during the 1st quarter. FAS Wealth Partners Inc. now owns 46,477 shares of the company’s stock valued at $759,000 after purchasing an additional 15,380 shares during the period. Bank of America Corp DE lifted its position in shares of Claritev by 146.6% in the 1st quarter. Bank of America Corp DE now owns 97,795 shares of the company’s stock worth $1,598,000 after purchasing an additional 58,133 shares during the period. RBF Capital LLC lifted its position in shares of Claritev by 0.8% in the 1st quarter. RBF Capital LLC now owns 135,314 shares of the company’s stock worth $2,211,000 after purchasing an additional 1,127 shares during the period. Public Employees Retirement System of Ohio purchased a new stake in shares of Claritev in the 1st quarter worth about $38,000. Finally, State of Wyoming boosted its stake in shares of Claritev by 239.2% during the 1st quarter. State of Wyoming now owns 2,018 shares of the company’s stock valued at $33,000 after purchasing an additional 1,423 shares in the last quarter. Institutional investors own 87.15% of the company’s stock.

About Claritev

Claritev is a healthcare technology, data and insights company focused on improving affordability,  transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.